Advancing Decentralized Clinical Trials
Advancing Decentralized Clinical Trials Through a Unified Approach to eCOA and DHTs
In an environment where patient centricity and value demonstration are becoming a greater focus for stakeholders across the healthcare spectrum, the need to understand the 360 degree view of the patient, together with improvements in measuring patient outcomes, is critical to success.
Combining independent data streams significantly boosts the value demonstration of new drugs, enabling comprehensive patient profiles that better inform how patients experience their disease and respond to treatment. This white paper details how having a unified approach to eCOA and digital health technologies (sensors & wearables) leads to a 360 degree patient view, which greatly improves drug value demonstrations, driving better patient outcomes.